Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions

Françoise Banères-Roquet1, Maxime Gualtieri, Philippe Villain-Guillot

  • 1CNRS-CPBS/UMR 5236, Faculté de Pharamcie, Montpellier Cedex 5, France. Jean-Paul.Leonetti@univ-montpl.fr

Insights

Surface plasmon resonance (SPR) precisely quantifies how antibiotics bind to serum proteins. This method offers valuable real-time kinetic data for drug development and understanding antibiotic efficacy.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Analytical Chemistry

Background:

  • Antibiotic efficacy depends on unbound drug concentration at infection sites.
  • Interactions with serum proteins can reduce the effective concentration of antibiotics.
  • Traditional methods for evaluating these interactions, like MIC testing in serum, can be limited.

Purpose of the Study:

  • To evaluate Surface Plasmon Resonance (SPR) as a tool for quantifying antibiotic-serum protein interactions.
  • To demonstrate SPR's ability to provide real-time kinetic data on these interactions.

Main Methods:

  • Utilized Surface Plasmon Resonance (SPR) technology.
  • Employed model antibiotics and serum proteins.
  • Quantified the real-time kinetics of antibiotic-serum protein binding.

Main Results:

  • SPR accurately quantified the interaction between model antibiotics and serum proteins.
  • SPR provided precise, real-time kinetic data on these critical binding events.
  • SPR emerged as a useful medium-throughput technology for hit validation.

Conclusions:

  • Surface Plasmon Resonance (SPR) is an effective automated tool for measuring antibiotic-serum protein interactions.
  • SPR offers valuable kinetic insights crucial for understanding and optimizing antibiotic pharmacologic effects.
  • SPR is a promising technology for drug development and validation processes.